WHO approves first Chinese Covid vaccine for emergency use

Sinopharm jab will also be added to Covax programme for the developing world in the coming weeks

The World Health Organization has given emergency use approval to one of the Chinese-made Sinopharm's Covid-19 vaccines in a major boost to the product's credibility.

The long-awaited decision made on Friday by a WHO technical advisory group would also see the Chinese vaccine being included in the Covax programme for the developing world in the coming weeks, and distributed through UN agencies, potentially benefiting millions of people in need worldwide.